You are required to be logged in to access the full website
Click here if you have forgotten your username or password
29 July 2026 - Biomaterials developer Auxilium Health has announced a rebrand and change of name to Aeris Biosciences.The name Aeris is designed to reflect what the company's biomaterials are at their core. "Aer" signals their foundati...
29 July 2026 - Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, announced on Tuesday that the US Food and Drug Administration (FDA) has acknowledged the company's resubmission of its New Drug Application (NDA) for SL10...
29 July 2026 - WuXi Biologics (HK:2269), a China-based global Contract Research, Development, and Manufacturing Organisation (CRDMO), announced on Tuesday that it has been included in the FTSE4Good Index Series in recognition of its outstanding susta...
28 July 2026 - Clinical-stage, AI-native biopharma company Lantern Pharma Inc (NASDAQ:LTRN) said on Tuesday that the European Medicines Agency (EMA) has cleared an investigator-initiated Phase 1b/2 clinical trial of LP-184 (zirdafulven) in patients w...
28 July 2026 - Generic pharmaceuticals manufacturer DifGen Pharmaceuticals LLC announced on Monday that the US Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application and issued a 'study may ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe